AB Volvo (publ) (0HTP)
London Exchange · UK · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 322.35 |
|---|---|
| 52-week range | 239.23 – 374.50 |
| Return, 1 month / 3 months | −3.2% / −5.3% |
| Return, 1 year / 3 years | +24.8% / +59.3% |
| Trend | Below its 200-day average |
| RSI (14) | 48 |
| Volatility (1 year) | 24.6% |
| Worst drawdown (1 year) | -17.5% |
| Average daily value traded | 352.10M SEK |
| Dividend yield | 2.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
AB Volvo is a Swedish industrial group that builds commercial vehicles. Its main products are heavy trucks, buses and coaches, and construction equipment such as excavators and wheel loaders, sold under brands including Volvo, Renault Trucks, Mack and Volvo Construction Equipment. Customers are haulage firms, bus operators, construction companies and public transport authorities, and the group also offers financing, servicing and spare parts for its vehicles. It is based in Gothenburg, Sweden.
On this site AB Volvo (publ) appears as a stock on the London Exchange (UK), code 0HTP, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
AB Volvo (publ) (0HTP) trades on the London Exchange in UK. It last closed at SEK 322.35 on 19 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 878 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 24.8% and over the last three months it fell 5.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -1.1% | ||
| From 52-week high | -13.1% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -5.3% | ||
| 6-month return | -0.5% | ||
| 12-month return, skipping the last month | 28.9% | ||
| Stability (higher is calmer) | 78 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.5% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 352.10M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 54 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.6% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.7% |
|---|---|
| 1 month | −3.2% |
| 3 months | −5.3% |
| 6 months | −0.5% |
| 1 year | +24.8% |
| 3 years | +59.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 333.56 / 326.08 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.47 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Apr 2026 | SEK 8.5000 |
| 3 Apr 2025 | SEK 10.5000 |
| 28 Mar 2024 | SEK 10.5000 |
| 5 Apr 2023 | SEK 14.0000 |
| 7 Apr 2022 | SEK 13.0000 |
| 30 Jun 2021 | SEK 9.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.